SIOX logo

Sio Gene Therapies (SIOX) Operating Profit

Annual Operating Profit

-$71.56 M
-$29.36 M-69.59%

31 March 2022

SIOX Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Profit

-$4.48 M
-$1.21 M-36.80%

31 December 2022

SIOX Quarterly Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Operating Profit

-$29.37 M
+$20.89 M+41.56%

31 December 2022

SIOX TTM Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SIOX Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-69.6%+82.3%+58.5%
5 y5 years+43.7%+67.2%+55.8%

SIOX Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time+69.6%+36.8%+18.1%

Sio Gene Therapies Operating Profit History

DateAnnualQuarterlyTTM
Dec 2022
-
-$4.48 M(+36.8%)
-$29.37 M(-41.6%)
Sept 2022
-
-$3.28 M(-61.6%)
-$50.26 M(-26.3%)
June 2022
-
-$8.53 M(-34.7%)
-$68.18 M(-4.7%)
Mar 2022
-$71.56 M(+69.6%)
-$13.08 M(-48.5%)
-$71.56 M(+1.2%)
Dec 2021
-
-$25.37 M(+19.7%)
-$70.69 M(+26.4%)
Sept 2021
-
-$21.20 M(+77.9%)
-$55.93 M(+26.3%)
June 2021
-
-$11.92 M(-2.4%)
-$44.28 M(+4.9%)
Mar 2021
-$42.20 M(-39.0%)
-$12.21 M(+15.1%)
-$42.20 M(-8.3%)
Dec 2020
-
-$10.61 M(+11.1%)
-$46.04 M(-6.3%)
Sept 2020
-
-$9.55 M(-2.9%)
-$49.11 M(-4.5%)
June 2020
-
-$9.83 M(-38.7%)
-$51.45 M(-25.6%)
Mar 2020
-$69.17 M(-45.5%)
-$16.05 M(+17.4%)
-$69.17 M(+4.1%)
Dec 2019
-
-$13.68 M(+15.1%)
-$66.42 M(-22.0%)
Sept 2019
-
-$11.88 M(-56.9%)
-$85.16 M(-19.2%)
June 2019
-
-$27.56 M(+107.1%)
-$105.40 M(-17.0%)
DateAnnualQuarterlyTTM
Mar 2019
-$127.02 M(-40.5%)
-$13.31 M(-59.0%)
-$127.02 M(-7.8%)
Dec 2018
-
-$32.42 M(+0.9%)
-$137.75 M(-14.3%)
Sept 2018
-
-$32.12 M(-34.7%)
-$160.72 M(-18.5%)
June 2018
-
-$49.17 M(+104.5%)
-$197.26 M(-7.5%)
Mar 2018
-$213.32 M(+18.2%)
-$24.04 M(-56.6%)
-$213.32 M(-12.0%)
Dec 2017
-
-$55.38 M(-19.4%)
-$242.37 M(+3.2%)
Sept 2017
-
-$68.67 M(+5.3%)
-$234.97 M(+13.1%)
June 2017
-
-$65.23 M(+22.9%)
-$207.82 M(+15.1%)
Mar 2017
-$180.50 M(+35.5%)
-$53.10 M(+10.7%)
-$180.50 M(+14.2%)
Dec 2016
-
-$47.97 M(+15.5%)
-$157.99 M(-8.4%)
Sept 2016
-
-$41.52 M(+9.5%)
-$172.57 M(+18.0%)
June 2016
-
-$37.91 M(+23.9%)
-$146.19 M(+9.8%)
Mar 2016
-$133.16 M
-$30.59 M(-51.1%)
-$133.16 M(+29.8%)
Dec 2015
-
-$62.55 M(+313.1%)
-$102.58 M(+156.3%)
Sept 2015
-
-$15.14 M(-39.1%)
-$40.02 M(+60.9%)
June 2015
-
-$24.88 M
-$24.88 M

FAQ

  • What is Sio Gene Therapies annual operaing income?
  • What is the all time high annual operating profit for Sio Gene Therapies?
  • What is Sio Gene Therapies quarterly operating income?
  • What is the all time high quarterly operating profit for Sio Gene Therapies?
  • What is Sio Gene Therapies TTM operating income?
  • What is the all time high TTM operating profit for Sio Gene Therapies?

What is Sio Gene Therapies annual operaing income?

The current annual operating profit of SIOX is -$71.56 M

What is the all time high annual operating profit for Sio Gene Therapies?

Sio Gene Therapies all-time high annual operaing income is -$42.20 M

What is Sio Gene Therapies quarterly operating income?

The current quarterly operating profit of SIOX is -$4.48 M

What is the all time high quarterly operating profit for Sio Gene Therapies?

Sio Gene Therapies all-time high quarterly operating income is -$3.28 M

What is Sio Gene Therapies TTM operating income?

The current TTM operating profit of SIOX is -$29.37 M

What is the all time high TTM operating profit for Sio Gene Therapies?

Sio Gene Therapies all-time high TTM operating income is -$24.88 M